Johnson & Johnson Stock News

CARVYKTI ®  is the first and only BCMA-targeted CAR-T cell therapy approved by the U.S. FDA for the treatment of patients with multiple myeloma who have had at least one prior line of therapy RARITA

Morningstar published 10 Best Value Stocks to Buy for the Long Term, undervalued blue-chip stocks with low price to fair value. Valuation and future return of each stock analyzed, compared to the S&P

Retirement stocks are something every investor needs to look into, and when deciding on which retirement stocks to buy, you can never go wrong with Dividend Kings, S&P 500 index constituents that have

High-yield dividend stocks have consistently attracted the attention of Wall Street investors. These stocks not only provide a steady income stream but also offer the potential for capital appreciatio

AbbVie is a Dividend King poised for growth. Gilead Sciences is a stable, low-risk candidate for investors.

Undervalued stocks, let's talk about them. Typically, when you come across a list of equities that are supposedly discounted, you're dealing with industry comparisons.

Dividends can boost your portfolio returns. Johnson & Johnson is a classic example of a value stock with a faithful dividend history.

A federal judge on Friday rejected a bid by a group of cancer victims to block Johnson & Johnson from pursuing a proposed bankruptcy settlement of tens of thousands of lawsuits alleging the company's

First-and-only FcRn blocker to demonstrate superiority in activities of daily living (MG-ADL a ) over placebo when added to standard of care over 24 weeks in antibody positive patients: anti-AChR+, an

The June/July 2024 edition of Fortune Magazine revealed the 500 biggest U.S. companies by-revenue and profits. Dogcatcher's quest for dividend buys focused-on 66 industry-eaders (IL) using YCharts 6/2

During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash

Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.

Dividend growth stocks have a remarkable history of generating above-average returns for investors. Here's a breakdown of two of the best stocks in the category.

Johnson & Johnson is trying a new approach to resolve thousands of outstanding talc lawsuits. The company's operations are growing in the mid-single digits, and investors can expect more of the same i

Dividend stocks are my favored way for generating passive income for retirement. Passive income is generated with minimal effort once set up, and can snowball beautifully as dividends are reinvested.